The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databasesGRIFFIN, James T; FRASER, Christophe; GRAS, Luuk et al.American journal of epidemiology. 2006, Vol 163, Num 7, pp 676-683, issn 0002-9262, 8 p.Article

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individualsVAN SIGHEM, Ard; GRAS, Luuk; REISS, Peter et al.AIDS (London). 2010, Vol 24, Num 10, pp 1527-1535, issn 0269-9370, 9 p.Article

Episodes of HIV Viremia and the Risk of Non-AIDS Diseases in Patients on Suppressive Antiretroviral TherapySHUANGJIE ZHANG; SIGHEM, Ard Van; KESSELRING, Anouk et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 3, pp 265-272, issn 1525-4135, 8 p.Article

The genotypic inhibitory quotient and the (cumulative) number of mutations predict the resnnnse to lopinavir theranvHOEFNAGEL, Jolanda G. M; VAN DER LEE, Manon J; KOOPMANS, Peter P et al.AIDS (London). 2006, Vol 20, Num 7, pp 1069-1071, issn 0269-9370, 3 p.Article

Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infectionGRIJSEN, Marlous L; HOLMAN, Rebecca; WIT, Ferdinand W. N. M et al.AIDS (London). 2012, Vol 26, Num 15, pp 1974-1977, issn 0269-9370, 4 p.Article

Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the NetherlandsKESSELRING, Anouk M; GRAS, Luuk; WIT, Ferdinand W et al.Antiviral therapy (London). 2010, Vol 15, Num 6, pp 871-879, issn 1359-6535, 9 p.Article

Clinical experience with the combined use of lopinavir/ritonavir and rifampicinL'HOMME, Rafaëlla F. A; NIJLAND, Hanneke M. J; GRAS, Luuk et al.AIDS (London). 2009, Vol 23, Num 7, pp 863-865, issn 0269-9370, 3 p.Article

Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohortVAN LELYVELD, Steven F. L; GRAS, Luuk; KESSELRING, Anouk et al.AIDS (London). 2012, Vol 26, Num 4, pp 465-474, issn 0269-9370, 10 p.Article

No advantage of quadruple― or triple―class antiretroviral therapy as initial treatment in patients with very high viraemiaGRIJSEN, Marlous L; HOLMAN, Rebecca; GRAS, Luuk et al.Antiviral therapy (London). 2012, Vol 17, Num 8, pp 1609-1613, issn 1359-6535, 5 p.Article

Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral TherapyKESSELRING, Anouk; GRAS, Luuk; SMIT, Colette et al.Clinical infectious diseases. 2011, Vol 52, Num 12, pp 1458-1465, issn 1058-4838, 8 p.Article

Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 controlVAN MANEN, Daniëlle; GRAS, Luuk; VAN 'T WOUT, Angélique B et al.AIDS (London). 2011, Vol 25, Num 18, pp 2217-2226, issn 0269-9370, 10 p.Article

Discontinuation of Nevirapine Because of Hypersensitivity Reactions in Patients with Prior Treatment Experience, Compared with Treatment-Naive Patients : The ATHENA Cohort StudyWIT, Ferdinand W. N. M; KESSELRING, Anouk M; GRAS, Luuk et al.Clinical infectious diseases. 2008, Vol 46, Num 6, pp 933-940, issn 1058-4838, 8 p.Article

CD4 cell counts of 800 cells/mm³ or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 Cells/mm³ or greaterGRAS, Luuk; KESSELRING, Anouk M; GRIFFIN, James T et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 2, pp 183-192, issn 1525-4135, 10 p.Article

Prolonged Decrease of CD4⁺ T Lymphocytes in HIV-1―Infected Patients After Radiotherapy for a Solid TumorSANKATSING, Sanjay U. C; HILLEBREGT, Mariska M. J; GRAS, Luuk et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 5, pp 546-549, issn 1525-4135, 4 p.Article

Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatmentSHUANGJIE ZHANG; VAN SIGHEM, Ard; GRAS, Luuk et al.Antiviral therapy (London). 2010, Vol 15, Num 4, pp 463-470, issn 1359-6535, 8 p.Article

Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz DiscontinuationsVAN LUIN, Matthijs; GRAS, Luuk; RICHTER, Clemens et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 240-245, issn 1525-4135, 6 p.Conference Paper

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. CommentaryBEZEMER, Daniela; DE WOLF, Frank; COATES, Thomas J et al.AIDS (London). 2008, Vol 22, Num 9, issn 0269-9370, 1071-1077, 1079-1080 [9 p.]Article

Immunologic, Virologic, and Clinical Consequences of Episodes of Transient Viremia During Suppressive Combination Antiretroviral TherapyVAN SIGHEM, Ard; SHUANGJIE ZHANG; REISS, Peter et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 1, pp 104-108, issn 1525-4135, 5 p.Article

Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?SCHOFFELEN, Annelot F; LELYVELD, Steven F. L. Van; BARTH, Roos E et al.AIDS (London). 2013, Vol 27, Num 7, pp 1179-1184, issn 0269-9370, 6 p.Article

Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmissionHERBECK, Joshua T; MÜLLER, Viktor; GOTTLIEB, Geoffrey S et al.AIDS (London). 2012, Vol 26, Num 2, pp 193-205, issn 0269-9370, 13 p.Article

Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first testGRAS, Luuk; VAN SIGHEM, Ard; BEZEMER, Daniela et al.AIDS (London). 2011, Vol 25, Num 6, pp 813-818, issn 0269-9370, 6 p.Article

The Efficacy of Combination Antiretroviral Therapy in HIV Type 1-Infected Patients Treated in Curaçao Compared with Antillean, Surinam, and Dutch HIV Type 1―Infected Patients Treated in The NetherlandsHERMANIDES, Hillegonda S; GRAS, Luuk; WINKEL, Carel N et al.AIDS research and human retroviruses. 2011, Vol 27, Num 6, pp 605-612, issn 0889-2229, 8 p.Article

Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosisTHIEBAUT, Rodolphe; LEROY, Valériane; ALIOUM, Ahmadou et al.European journal of obstetrics, gynecology, and reproductive biology. 2006, Vol 124, Num 1, pp 3-9, issn 0301-2115, 7 p.Article

Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individualsVAN SIGHEM, Ard; DANNER, Sven; GHANI, Azra C et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 40, Num 2, pp 212-218, issn 1525-4135, 7 p.Article

Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy : A cohort study in 13 European centresGRAS, Luuk; WALLON, Martine; POLLAK, Arnold et al.Acta paediatrica (Oslo). 2005, Vol 94, Num 12, pp 1721-1731, issn 0803-5253, 11 p.Article